Age and Its Association with Low Insulin and High Amyloid-β Peptides in Blood

Huajie Li, Haihao Zhu, Max Wallack, Mkaya Mwamburi, Samer O. Abdul-Hay, Malcolm A. Leissring, Wei Qiao Qiu

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Age is the major risk factor for developing Alzheimer's disease (AD), and modifying age-related factors may help to delay the onset of the disease. The goal of this study was to investigate the relationship between age and the metabolic factors related to the risk of developing AD. The concentrations of insulin, amylin, and amyloid-β peptide (Aβ) in plasma were measured. We further measured the activity of serum Aβ degradation by using fluorescein-and biotin-labeled Aβ40. Apolipoprotein E4 allele (ApoE4) and cognitive impairment were characterized. Subjects were divided into three age groups: 60-70, 70-80, and ≥80 years old. We found that the older the subjects, the lower the concentration of insulin (p=0.001) and the higher the concentration of Aβ1-40 (p=0.004) in plasma. However, age was not associated with the concentration of another pancreatic peptide, amylin, and only marginally with Aβ1-42. These relationships remained in the absence of diabetes, cardiovascular disease, and stroke, and regardless of the presence of ApoE4 and cognitive impairment. Both age and ApoE4 were inversely associated with, while insulin was positively associated with, the activities of Aβ degradation in serum. Our study suggested that low concentration of insulin and high concentration of Aβ40 are aging factors related to the risk of AD.

Original languageEnglish (US)
Pages (from-to)129-137
Number of pages9
JournalJournal of Alzheimer's Disease
Volume49
Issue number1
DOIs
StatePublished - 2015

Fingerprint

Apolipoprotein E4
Amyloid
Insulin
Islet Amyloid Polypeptide
Alzheimer Disease
Peptides
Age Factors
Alleles
Biotin
Fluorescein
Serum
Cardiovascular Diseases
Age Groups
Myocardial Infarction
Cognitive Dysfunction

Keywords

  • age
  • Alzheimer's disease
  • ApoE4
  • Aβdegradation
  • insulin

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology

Cite this

Li, H., Zhu, H., Wallack, M., Mwamburi, M., Abdul-Hay, S. O., Leissring, M. A., & Qiu, W. Q. (2015). Age and Its Association with Low Insulin and High Amyloid-β Peptides in Blood. Journal of Alzheimer's Disease, 49(1), 129-137. https://doi.org/10.3233/JAD-150428

Age and Its Association with Low Insulin and High Amyloid-β Peptides in Blood. / Li, Huajie; Zhu, Haihao; Wallack, Max; Mwamburi, Mkaya; Abdul-Hay, Samer O.; Leissring, Malcolm A.; Qiu, Wei Qiao.

In: Journal of Alzheimer's Disease, Vol. 49, No. 1, 2015, p. 129-137.

Research output: Contribution to journalArticle

Li, H, Zhu, H, Wallack, M, Mwamburi, M, Abdul-Hay, SO, Leissring, MA & Qiu, WQ 2015, 'Age and Its Association with Low Insulin and High Amyloid-β Peptides in Blood', Journal of Alzheimer's Disease, vol. 49, no. 1, pp. 129-137. https://doi.org/10.3233/JAD-150428
Li, Huajie ; Zhu, Haihao ; Wallack, Max ; Mwamburi, Mkaya ; Abdul-Hay, Samer O. ; Leissring, Malcolm A. ; Qiu, Wei Qiao. / Age and Its Association with Low Insulin and High Amyloid-β Peptides in Blood. In: Journal of Alzheimer's Disease. 2015 ; Vol. 49, No. 1. pp. 129-137.
@article{2d66175b86974fc288216ee15b5530f0,
title = "Age and Its Association with Low Insulin and High Amyloid-β Peptides in Blood",
abstract = "Age is the major risk factor for developing Alzheimer's disease (AD), and modifying age-related factors may help to delay the onset of the disease. The goal of this study was to investigate the relationship between age and the metabolic factors related to the risk of developing AD. The concentrations of insulin, amylin, and amyloid-β peptide (Aβ) in plasma were measured. We further measured the activity of serum Aβ degradation by using fluorescein-and biotin-labeled Aβ40. Apolipoprotein E4 allele (ApoE4) and cognitive impairment were characterized. Subjects were divided into three age groups: 60-70, 70-80, and ≥80 years old. We found that the older the subjects, the lower the concentration of insulin (p=0.001) and the higher the concentration of Aβ1-40 (p=0.004) in plasma. However, age was not associated with the concentration of another pancreatic peptide, amylin, and only marginally with Aβ1-42. These relationships remained in the absence of diabetes, cardiovascular disease, and stroke, and regardless of the presence of ApoE4 and cognitive impairment. Both age and ApoE4 were inversely associated with, while insulin was positively associated with, the activities of Aβ degradation in serum. Our study suggested that low concentration of insulin and high concentration of Aβ40 are aging factors related to the risk of AD.",
keywords = "age, Alzheimer's disease, ApoE4, Aβ, Aβdegradation, insulin",
author = "Huajie Li and Haihao Zhu and Max Wallack and Mkaya Mwamburi and Abdul-Hay, {Samer O.} and Leissring, {Malcolm A.} and Qiu, {Wei Qiao}",
year = "2015",
doi = "10.3233/JAD-150428",
language = "English (US)",
volume = "49",
pages = "129--137",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - Age and Its Association with Low Insulin and High Amyloid-β Peptides in Blood

AU - Li, Huajie

AU - Zhu, Haihao

AU - Wallack, Max

AU - Mwamburi, Mkaya

AU - Abdul-Hay, Samer O.

AU - Leissring, Malcolm A.

AU - Qiu, Wei Qiao

PY - 2015

Y1 - 2015

N2 - Age is the major risk factor for developing Alzheimer's disease (AD), and modifying age-related factors may help to delay the onset of the disease. The goal of this study was to investigate the relationship between age and the metabolic factors related to the risk of developing AD. The concentrations of insulin, amylin, and amyloid-β peptide (Aβ) in plasma were measured. We further measured the activity of serum Aβ degradation by using fluorescein-and biotin-labeled Aβ40. Apolipoprotein E4 allele (ApoE4) and cognitive impairment were characterized. Subjects were divided into three age groups: 60-70, 70-80, and ≥80 years old. We found that the older the subjects, the lower the concentration of insulin (p=0.001) and the higher the concentration of Aβ1-40 (p=0.004) in plasma. However, age was not associated with the concentration of another pancreatic peptide, amylin, and only marginally with Aβ1-42. These relationships remained in the absence of diabetes, cardiovascular disease, and stroke, and regardless of the presence of ApoE4 and cognitive impairment. Both age and ApoE4 were inversely associated with, while insulin was positively associated with, the activities of Aβ degradation in serum. Our study suggested that low concentration of insulin and high concentration of Aβ40 are aging factors related to the risk of AD.

AB - Age is the major risk factor for developing Alzheimer's disease (AD), and modifying age-related factors may help to delay the onset of the disease. The goal of this study was to investigate the relationship between age and the metabolic factors related to the risk of developing AD. The concentrations of insulin, amylin, and amyloid-β peptide (Aβ) in plasma were measured. We further measured the activity of serum Aβ degradation by using fluorescein-and biotin-labeled Aβ40. Apolipoprotein E4 allele (ApoE4) and cognitive impairment were characterized. Subjects were divided into three age groups: 60-70, 70-80, and ≥80 years old. We found that the older the subjects, the lower the concentration of insulin (p=0.001) and the higher the concentration of Aβ1-40 (p=0.004) in plasma. However, age was not associated with the concentration of another pancreatic peptide, amylin, and only marginally with Aβ1-42. These relationships remained in the absence of diabetes, cardiovascular disease, and stroke, and regardless of the presence of ApoE4 and cognitive impairment. Both age and ApoE4 were inversely associated with, while insulin was positively associated with, the activities of Aβ degradation in serum. Our study suggested that low concentration of insulin and high concentration of Aβ40 are aging factors related to the risk of AD.

KW - age

KW - Alzheimer's disease

KW - ApoE4

KW - Aβ

KW - Aβdegradation

KW - insulin

UR - http://www.scopus.com/inward/record.url?scp=84948704529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948704529&partnerID=8YFLogxK

U2 - 10.3233/JAD-150428

DO - 10.3233/JAD-150428

M3 - Article

AN - SCOPUS:84948704529

VL - 49

SP - 129

EP - 137

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 1

ER -